lansoprazole has been researched along with Kidney Failure, Chronic in 5 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okamoto, T | 1 |
| Hatakeyama, S | 1 |
| Hosogoe, S | 1 |
| Tanaka, Y | 1 |
| Imanishi, K | 1 |
| Takashima, T | 1 |
| Saitoh, F | 1 |
| Suzuki, T | 1 |
| Ohyama, C | 1 |
| Sheu, BS | 1 |
| Huang, JJ | 1 |
| Yang, HB | 1 |
| Huang, AH | 1 |
| Wu, JJ | 1 |
| Tsukada, K | 1 |
| Katoh, H | 1 |
| Miyazaki, T | 1 |
| Kuwano, H | 1 |
| Itatsu, T | 1 |
| Miwa, H | 1 |
| Nagahara, A | 1 |
| Kubota, M | 1 |
| Miyazaki, A | 1 |
| Sato, N | 1 |
| Hayashida, Y | 1 |
| Tamura, H | 1 |
| Tokushima, H | 1 |
| Murakawa, M | 1 |
| Matsumura, O | 1 |
| Itoyama, S | 1 |
| Sekine, S | 1 |
| Hirose, H | 1 |
| Mitarai, T | 1 |
| Isoda, K | 1 |
1 review available for lansoprazole and Kidney Failure, Chronic
| Article | Year |
|---|---|
[Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dialysi | 2005 |
2 trials available for lansoprazole and Kidney Failure, Chronic
| Article | Year |
|---|---|
The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; | 2003 |
Eradication of Helicobacter pylori in hemodialysis patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial | 2007 |
2 other studies available for lansoprazole and Kidney Failure, Chronic
| Article | Year |
|---|---|
Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.
Topics: Aged; Aorta, Abdominal; Computed Tomography Angiography; Disease Progression; Esomeprazole; Female; | 2018 |
Eradication of Helicobacter pylori in patients with end-stage renal disease under dialysis treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Comb | 1997 |